Introduction {#sec1-1}
============

Apoptosis or programmed cell death is a normal process to remove candidate cells for death ([@ref1]). Accordingly, this is a physiological process for progression and homeostasis of human systems such as immune and nervous systems ([@ref2]). Previous investigations revealed that several endogenous and exogenous agents can induce apoptosis ([@ref3], [@ref4]). Alkaloids (morphine, heroine and codeine) are the important exogenous agents which induce apoptosis ([@ref5]). There are more than 20 alkaloids ([@ref5]) and more than 70 components ([@ref6]) in opium, thus, its effect on the cells could be different from its derivatives. Our previous studies demonstrated that chronic opium treatment can induce brain and liver cell apoptosis in rats ([@ref7]) and apoptosis in Jurkat cells ([@ref8]). Additionally, we have reported that opium can decreased mean number of peripheral white blood cells in animal models ([@ref9]). Moreover, it has been demonstrated that opium addicted individuals suffer from an attenuated immune responses and repeated infectious diseases ([@ref10], [@ref11]). Therefore, it appears that opium can induce apoptosis in immune cells via unknown pathway. Jurkat cells are lymphocyte cancer cell lines which are used in several malignancies and immune responses based studies ([@ref12]). Due to the fact that the main molecules and pathways which are involved in the apoptosis induced by opium are yet to be identified and based on the fact that opium can induce apoptosis in Jurkat cells ([@ref8]), hence, the main aim of this study was to evaluate expression of reference genes involved in the apoptosis pathways using Real-Time PCR Array technique.

Materials and Methods {#sec1-2}
=====================

Cell culture, opium treatment and cell survival analysis {#sec2-1}
--------------------------------------------------------

Cell culture condition has been described in our previous study ([@ref8]). Briefly, Jurkat cells were prepared from Pasture Institute of Iran and were cultured in RPMI1640 culture medium (Invitrogen Co. Germany) in standard condition. Opium dedication, its origin, components (using GC-mass spectrometry) and appropriate dilution for inducing apoptosis have also been described previously ([@ref8], [@ref11]). According to our previous study which demonstrated that, opium dilution at concentration of 2.86 × 10^-5^ and after 48 hr were the optimum concentration and time of culture

for induction of apoptosis in Jurkat cells, respectively, hence Jurkat cells were treatment at the concentration and incubation period. The apoptotic changes were evaluated using an annexin-V and propidium iodide (PI) commercial kit (Invitrogen, USA) according to the manufacturer's guidelines. Briefly, the washed jurkat cells (\~5 × 10 [@ref5] cells) were resuspended in 100 μl 1X annexin-binding buffer and then 5 μl annexin V and the 5 μl PI were added to each 100 μl of cell suspension. The cells mixed gently and then incubated in a dark place at room temperature for 10 min. After incubation period, apoptotic cells were quantified by the BD flow cytometry system.

RNA extraction, reverse transcription and quantitative real-time PCR {#sec2-2}
--------------------------------------------------------------------

Total RNA was purified from opium treated and untreated Jurkat cells using RNX quality extraction kit (Cinnaclon Co, Tehran-Iran). The RNA quality was measured on 260/280 nm by spectrophotometer. RNA were convert to cDNA using a commercial cDNA synthesis kit and oligo(dT) primers from Parstous Company, Tehran-Iran, which is described in our previous study ([@ref13]). Expression levels of ABL1, AKT1, APAF1, BAD, BAG1, BAG3, BAG4, BAK1, BAX, BCL10, BCL2, BCL2A1, BCL2L1, BCL2L10, BCL2L11, BCL2L2, BCLAF1, BFAR, BID, BIK, NAIP, BIRC2, BIRC3, XIAP, BIRC6, BIRC8, BNIP1, BNIP2, BNIP3, BNIP3L, BRAF, NOD1, CARD6, CARD8, CASP1, CASP10, CASP14, CASP2, CASP3, CASP4, CASP5, CASP6, CASP7, CASP8, CASP9, CD40, CD40LG, CFLAR, CIDEA, CIDEB, CRADD, DAPK1, DFFA, FADD, FAS, FASLG, GADD45A, HRK, IGF1R, LTA, LTBR, MCL1, NOL3, PYCARD, RIPK2, TNF, TNFRSF10A, TNFRSF10B, TNFRSF11B, TNFRSF1A, TNFRSF21, TNFRSF25, CD27, TNFRSF9, TNFSF10, CD70, TNFSF8, TP53, TP53BP2, TP73, TRADD, TRAF2, TRAF3 and TRAF4 were measured by quantitative Real-Time PCR

Array technique using a commercial kit (SABiosciences company, USA). The full names of the genes are defined in the [Table 1](#T1){ref-type="table"}. The levels of mRNA of B2M, HPRT1, RPL13A, GAPDH, ACTB and HGDC have been evaluated as housekeeping genes and were used for normalization of the results. Bio-Rad CFX96 instrument have been used for running the PCR array plates. Raw data were analyzed using RT² Profiler PCR Array Data Analysis software version 3.5.

###### 

Relative expression levels of apoptosis related genes in opium treated Jurkat cells in comparison to untreated cells

  BAD         Bcl-2-associated death promoter                                    -1.0559   C
  ----------- ------------------------------------------------------------------ --------- ---
  BAG1        BCL2-associated athanogene 1                                       -1.4775   B
  BAG3        BCL2-associated athanogene 3                                       -1.2643   B
  BAG4        BCL2-associated athanogene 4                                       -1.0559   C
  BAK1        Bcl-2 homologous antagonist/killer                                 -1.0559   C
  BAX         Bcl-2-associated X protein                                         1.6994    B
  BCL10       B-cell CLL/lymphoma 10                                             -1.0559   C
  BCL2        B-cell CLL/lymphoma 2                                              3.7425    B
  BCL2A1      BCL2-related protein A1                                            -1.0559   C
  BCL2L1      BCL2-like 1                                                        1.2633    B
  BCL2L10     BCL2-like 10                                                       -1.0559   C
  BCL2L11     BCL2-like 11                                                       1.1283    B
  BCL2L2      BCL2-like 2                                                        -1.0965   B
  BCLAF1      Bcl-2-associated transcription factor 1                            -2.8543   B
  BFAR        Bifunctional apoptosis regulator                                   1.1417    B
  BID         BH3 interacting-domain death agonist                               1.7735    B
  BIK         Bcl-2-interacting killer                                           -1.0559   C
  NAIP        NLR family, apoptosis inhibitory protein                           1.1244    B
  BIRC2       Baculoviral IAP repeat containing 2                                -1.0559   C
  BIRC3       Baculoviral IAP repeat containing 3                                -1.0559   C
  XIAP        X-linked inhibitor of apoptosis                                    1.9629    B
  BIRC6       Baculoviral IAP repeat containing 6                                1.9136    B
  BIRC8       Baculoviral IAP repeat containing 8                                -1.0559   C
  BNIP1       BCL2/adenovirus E1B 19kDa interacting protein 1                    -1.0559   C
  BNIP2       BCL2/adenovirus E1B 19kDa interacting protein 2                    -1.1135   B
  BNIP3       BCL2/adenovirus E1B 19kDa interacting protein 3                    2.7924    B
  BNIP3L                                                                         1.2793    B
  BRAF        V-raf murine sarcoma viral oncogene homolog B1                     -1.1081   B
  NOD1        Nucleotide-binding oligomerization domain-containing protein 1     2.0889    B
  CARD6       Caspase-associated recruitment domain 6                            -1.0559   C
  CARD8       Caspase-associated recruitment domain 8                            -1.0559   C
  CASP1       Caspase 1, apoptosis-related cysteine peptidase                    1.2434    B
  CASP10      Caspase 10, apoptosis-related cysteine peptidase                   -1.0559   C
  CASP14      Caspase 14, apoptosis-related cysteine peptidase                   -1.0559   C
  CASP2       Caspase 2, apoptosis-related cysteine peptidase                    -1.0559   C
  CASP3       Caspase 3, apoptosis-related cysteine peptidase                    2.447     B
  CASP4       Caspase 4, apoptosis-related cysteine peptidase                    2.3947    B
  CASP5       Caspase 5, apoptosis-related cysteine peptidase                    1.3686    B
  CASP6       Caspase 6, apoptosis-related cysteine peptidase                    2.914     B
  CASP7       Caspase 7, apoptosis-related cysteine peptidase                    1.5241    B
  CASP8       Caspase 8, apoptosis-related cysteine peptidase                    -1.0559   C
  CASP9       Caspase 9, apoptosis-related cysteine peptidase                    -2.3438   B
  CD40        CD40 molecule                                                      -1.0559   C
  CD40LG      CD40 ligand                                                        -1.0559   C
  CFLAR       Caspase 8 and FADD-like apoptosis regulator                        1.362     B
  CIDEA       Cell death activator CIDE-A                                        -1.0559   C
  CIDEB       Cell death activator CIDE-B                                        -1.0559   C
  CRADD       Death domain-containing protein CRADD                              1.4186    B
  DAPK1       Death-associated protein kinase 1                                  -1.0559   C
  DFFA        DNA fragmentation factor subunit alpha                             3.696     B
  FADD        Fas-Associated protein with Death Domain                           -1.0559   C
  FAS         Fas (TNF receptor superfamily, member 6)                           -1.0559   C
  FASLG       Fas ligand                                                         -1.0559   C
  GADD45A     Growth arrest and DNA-damage-inducible protein GADD45 alpha        -1.0559   C
  HRK         Activator of apoptosis harakiri                                    -1.0559   C
  IGF1R       Insulin-like growth factor 1 receptor                              1.1879    B
  LTA         Lymphotoxin alpha                                                  -1.0559   C
  LTBR        Lymphotoxin beta receptor                                          3.0613    B
  MCL1        Myeloid cell leukemia sequence 1 (BCL2-related)                    1.9438    A
  NOL3        Nucleolar protein 3                                                2.7685    B
  PYCARD      Apoptosis-associated speck-like protein containing a CARD or ASC   -1.0559   C
  RIPK2       Receptor-interacting serine/threonine-protein kinase 2             -2.0398   B
  TNF         Tumor necrosis factor                                              1.675     B
  TNFRSF10A   Tumor necrosis factor receptor superfamily, member 10a             -1.0559   C
  TNFRSF10B   Tumor necrosis factor receptor superfamily, member 10b             -1.0559   C
  TNFRSF11B   Tumor necrosis factor receptor superfamily, member 11b             -1.0559   C
  TNFRSF1A    Tumor necrosis factor receptor superfamily, member 1a              2.3709    B
  TNFRSF21    Tumor necrosis factor receptor superfamily, member 21              1.1407    B
  TNFRSF25    Tumor necrosis factor receptor superfamily, member 25              -1.0559   C
  CD27        CD27 molecule                                                      -3.8684   B
  TNFRSF9     Tumor necrosis factor receptor superfamily, member 9               -1.0559   C
  TNFSF10     Tumor necrosis factor superfamily, 10                              -1.0559   C
  CD70        CD70 molecule                                                      1.0352    B
  TNFSF8      Tumor necrosis factor superfamily, 8                               -1.0559   C
  TP53        Tumor protein p53                                                  -1.2672   B
  TP53BP2     Tumor suppressor p53-binding protein 2                             3.059     B
  TP73        Tumor protein p73                                                  -1.0559   C
  TRADD       Tumor necrosis factor receptor type 1-associated DEATH domain      -1.1042   B
  TRAF2       TNF receptor-associated factor 2                                   -1.6347   B
  TRAF3       TNF receptor-associated factor 3                                   -1.1836   B
  TRAF4       TNF receptor-associated factor 4                                   1.1343    B

**A:** Although, expression levels of the gene is increased in opium treated Jurkat cells in comparison to untreated cells, but the difference is not significant

**B:** The differences between groups are significant (Negative: decreased, Positive: Increased)

**C:** Although, expression levels of the gene is decreased in opium treated Jurkat cells in comparison to untreated cells, but the difference is not significant

Results {#sec1-3}
=======

The results showed that 50.3 ± 0.2 percent of Jurkat cells were shown apoptotic features after 48 hrs incubation with 2.86×10^-5^ g/ml opium concentration (*P*\< 0.001) ([Figure 1](#F1){ref-type="fig"}).

![The percent of Jurkat cells apoptosis at different concentrations of opium after 48 hrs incubation. The Figure illustrates that 50.3 ± 0.2 percent of Jurkat cells illustrated apoptotic features in opium with 2.86× 10 -5 g/ml concentration (*P*\< 0.001)](IJBMS-19-215-g001){#F1}

Our results demonstrated that expression levels of ABL1, BCL2, BNIP3, NOD1, CASP3, CASP4, CASP6, DFFA, LTBR, NOL3, TNFRSF1A and TP53BP2 were increased more than two folds, while, mRNA levels of BCLAF1, CASP9, RIPK2 and CD27 were decreased more than two folds ([Table 1](#T1){ref-type="table"} and [Figure 2](#F2){ref-type="fig"}). The expressions of other molecules were not changed after treatment with opium ([Table 1](#T1){ref-type="table"} and [Figure 1](#F1){ref-type="fig"}).

![The Figure showed relative expression levels of evaluated molecules which participate in apoptosis in opium treated Jurkat cells in comparison to no treated cells. Red and green colors demonstrated increase and decrease, respectively, expression of the molecules](IJBMS-19-215-g002){#F2}

Discussion {#sec1-4}
==========

Our previous studies demonstrated that opium induced apoptosis in *in vivo* and *in vitro* models ([@ref8], [@ref11]). The results of current study also demonstrated that apoptosis were increased in opium treated Jurkat cells. The results revealed that expression levels of pro-apoptotic molecules including ABL1 have been increased in the opium treated Jurkat cells. Previous studies demonstrated that ABL1 is a cytoplasmic and nuclear protein tyrosine kinase which participates in several cell functions including differentiation, division, adhesion and stress response ([@ref14]). Based on the fact that differentiation is decreased in cancer cells, hence, according to our results it appears that opium components may increase differentiation and reduce immortal properties of cells. The results also demonstrated that mRNA levels of BNIP3, NOD1, LTA, TNFRSF1A and TP53BP2, as pro-apoptotic molecules, were increased more than two folds in opium treated Jurkat cells. BNIP3 is a mitochondrial protein and results in apoptosis, even in the presence of BCL2. Our results showed that mRNA levels of BCL2, as anti-apoptotic molecule, were also increased in the opium treated cells. According to the results it appears that increased expression of BNIP3 overcome BCL2 and induced apoptosis in the opium treated cells. NOD1 is an inflammasome which participates in induction of apoptosis via activation of NF-κB ([@ref15]). Based on the fact that NODs have a LRR (Leucine-rich repeated) domain it appears that some opium derivatives may directly or via unknown intermediate molecules were recognized by NOD1 to induce apoptosis in Jurkat cells. LTBR is an receptor for pro-apoptotic molecule, lymphotoxin (LTA), which produced by lymphocytes and LTBR/LTA interaction induces apoptosis ([@ref16]). LTBR induces apoptosis via interaction with second mitochondria-derived activator of caspases (SMAC) and consequently activation of caspases ([@ref17]). Additionally, TNFRSF1A is a subunit of TNF receptor for TNF-α which in association with TNFRSF1B plays key roles in stimulation of apoptosis through TNFR1 ([@ref18]). Moreover, it has been reported that LTA can use TNFR1 to induce apoptosis ([@ref16]). Therefore, it appears that the LTA/LTBR, LTA/TNFR1 and TNF/TNFR1 pathways play crucial roles in induction of opium induced apoptosis in the Jurkat cell line. Interestingly, mRNA levels of TP53, a tumor suppressor molecule, were not changed after opium treatment but TP53BP2 were increased ([Table 1](#T1){ref-type="table"}). This molecule is a binding protein which interacts with TP53 and multiplied function of this molecule and, hence, induces apoptosis ([@ref19]). TP53BP2 promotes transcription of pro-apoptotic molecules via enhances the DNA binding and trans activation function of TP53 on the promoter region of the related genes ([@ref20]). Therefore, it appears that opium increased apoptotic features of TP53 via promotion of its function rather than its expression. Additionally, expression levels of CASP3, CASP4 and CASP6 were also increased after opium treatment ([Table 1](#T1){ref-type="table"}). These molecules are the intermediated pro-apoptotic molecules which mediate apoptosis via intrinsic and extrinsic pathways in a common manner ([@ref21]). Based on the fact that mRNA levels of CASP9 were decreased more than two folds in the opium treated cells, hence, it seems that opium mainly induces apoptosis via extrinsic pathway, which is confirmed by increased expression of LTA and TNFRSF1A molecules. In contrast with apoptotic features of opium treated Jurkat cells, mRNA levels of some of the anti-apoptotic molecules, including BCL2, DFFA and NOL3 were increased in the cells. As mentioned in the previous sentences, BNIP3 can induce apoptosis even in the presence of anti-apoptotic molecules such as BCL2. Based on the fact that extrinsic pathway may be the main route for induction of apoptosis in the opium treated cells, it seems that increased expression of NOL3 is a normal response of the cells to escape from death through suppress function of CASP8, because NOL3 inhibits apoptosis via interaction with CASP8 ([@ref22]).

The results revealed that three pro-apoptotic molecules including BCLAF1 (a transcriptional repressor factor from Bcl-2 family proteins) CD27 (a member of the TNF-receptor super family) and RIPK2 (containing of a C-terminal caspase recruitment domain (CARD)) were also down-regulated in the opium treated group. Thus, it may be concluded that opium induced apoptosis in BCLAF1, CD27 and RIPK2 independent manner. Although, there are several studies regarding the roles of alkaloids on the apoptosis and also the roles of opium on the induction of apoptosis but its molecular mechanisms are yet to be identified. Our study elucidates some of important pathways which participate in the induction of apoptosis by opium.

Conclusion {#sec1-5}
==========

Collectively, it seems that opium leads to induction of apoptosis in Jurkat cells via both intrinsic and extrinsic pathways. Additionally, although opium induces apoptosis in the cells but elevated expression of some anti-apoptotic molecules may be a normal resistance of the cell for death.
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